Trials / Completed
CompletedNCT00365014
Progression of Hematopoietic Diseases in Shanghai, China
Analysis of Disease Progression for Aplastic Anemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia and Benzene Poisoning in Shanghai, China.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10,757 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristics, benzene or other exposures and genetic susceptibility.
Detailed description
The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristics, benzene or other exposures and genetic susceptibility. The format for these studies is a set of clinical series superimposed on a case-control design that enables integration of detailed clinical and molecular characterizations of disease pathogenesis together with an evaluation of potential confounding and interacting factors within a structured statistical analysis of benzene exposure.
Conditions
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2006-08-16
- Last updated
- 2013-07-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00365014. Inclusion in this directory is not an endorsement.